ArticleJournal of thoracic disease2018

Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs.

Alessandro Lupi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.